The mentioned mutated genes as well as a number of involved epigenetic events occurring in melanoma cells contribute to the dysregulation of several signaling pathways comprising hyperactivated BRAF-MEK, PI3K/PTEN, or c-KIT cascades [3]. This evidence concerns the gene BRAF and melanoma.